FDA inspection

Biovectra Inc.: FDA inspection ending Sep 12, 2024

FDA inspection 1261629 · Official Action Indicated (OAI) · Windsor

Key facts

Inspection ID 1261629
Firm Biovectra Inc.
FEI number 3015684350
Address 24 Ivey Ln
City Windsor
Fiscal year 2024
Inspection end date Sep 12, 2024
Classification Official Action Indicated (OAI)
Project area New Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections